Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants

We compared the risks of switching to another oral anticoagulant (OAC) and discontinuation of direct oral anticoagulants (DOACs) among elderly patients with nonvalvular atrial fibrillation (NVAF) who were prescribed rivaroxaban or dabigatran versus apixaban. Patients (≥65 years of age) with NVAF pre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Appl Thromb Hemost
Hauptverfasser: Baker, Christine L., Dhamane, Amol D., Rajpura, Jigar, Mardekian, Jack, Dina, Oluwaseyi, Russ, Cristina, Rosenblatt, Lisa, Lingohr-Smith, Melissa, Lin, Jay
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publications 2019
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6829636/
https://ncbi.nlm.nih.gov/pubmed/31418293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029619870249
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge